Delivery Order SPE2DB22D1106-SPE2DB25FFCZ5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $1,274.62. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $2,749.94 delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on July 24, 2025, with a completion date of July 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count units) with a ceiling value of $4,354.56. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on July 29, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count units) with a contract ceiling value of $1,501.57. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of August 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, valued at $1,804.72. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with a ceiling value of $2,596.57. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 4, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Ambien CR 6.25 mg tablets (100 count) with a ceiling value of $1,610.42. This competitive, firm fixed price delivery order was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a...
- The Defense Logistics Agency awarded a $4,118.84 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on July 22, 2025, with ultimate completion scheduled for July 23, 2025. This contract utilizes firm fixed pricing and carries no set-aside designation, reflecting a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $15,429.77 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units). This non-competitive, firm fixed-price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,220.84 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) under a firm fixed-price contract. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, with no set-aside designation. Performance will occur at the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFCZ5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count packaging) on August 13, 2025, with a ceiling value of $1,715.50 and an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains, including brand-name and generic medications, vaccines, and specialized medical devices. This delivery order for neurological treatment medication reflects AmerisourceBergen's ongoing role in supporting Defense Health Agency requirements and broader government healthcare operations through its comprehensive pharmaceutical prime vendor agreement with the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/13/25 |